The transaction was approved by both companies' boards and includes a significant premium over recent stock prices for ...

Novartis has reached an agreement to buy Regulus Therapeutics and its experimental therapy for autosomal dominant polycystic kidney disease (ADPKD) for $800 million upfront in a deal that could ...

Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed ...

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for ALYFTREK ® (deutivacaftor/tezacaftor/vanzacaftor) for the treatment of people with cystic ...

In another departure from its core focus on genetic medicines, Vertex Pharma has agreed a $4.9 billion purchase of Alpine Immune Sciences, adding a mid-stage drug candidate for kidney disease IgA ...

Wall Street ended the first day of July 2025 on a mixed note. While the S&P 500 and Nasdaq suffered a fall, the Dow Jones Industrial Average gained a little. The contrasting movement witnessed across ...

POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for ...

There are many types of liver disease, ranging from those that are treatable to those that require a liver transplant. Learn about symptoms, causes, and more.

Nephrology articles from across Nature Portfolio Atom RSS Feed Nephrology is specialty of medicine concerned with kidney physiology, kidney disease, the treatment of kidney problems and renal ...